United Therapeutics secures FDA clearance for PAH Phase I trial
United Therapeutics has received clearance from the US Food and Drug Administration (FDA) under an investigational new drug application (IND)…
All articles by Salong Debbarma
Salong Debbarma
-
-
First patient dosed in Nacuity’s Phase III Usher syndrome RP trial
Nacuity Pharmaceuticals has dosed the first patient in its global confirmatory Phase III SLO-RP Preserve study, evaluating NPI-001 for retinitis…
-
Walmart and Care Access to open three clinical trial centres in US
The Walmart Healthcare Research Institute (WHRI) and Care Access are set to launch three further clinical trial centres in the…
-
Vanda reports Phase III tradipitant trial data in GLP-1-associated vomiting
Vanda Pharmaceuticals has reported positive results from the Phase III clinical trial, Study 3601 (VP-VLY-686-3601), assessing its oral therapy Nereus…
-
Mirum reports Phase II zilurgisertib trial data in paediatric FOP
Mirum Pharmaceuticals has reported positive data from cohort 2 of the pivotal Phase II PROGRESS trial assessing Atebrioz (zilurgisertib) in…
-
First patient dosed in Enanta’s Phase IIb/III trial for RSV
Enanta Pharmaceuticals has dosed the first patient in its global Phase IIb/III RESOLVE trial assessing zelicapavir in high-risk adult outpatients…
-
Alnylam reports preliminary Phase Ib trial results for brezosiran
Alnylam Pharmaceuticals has reported preliminary results from an ongoing Phase Ib clinical study assessing its investigational ribonucleic acid interference (RNAi)…
-
Pfizer reports Phase II data for 25vPnC infant vaccine candidate
Pfizer has reported findings from a Phase II trial assessing PF-07872412 (25vPnC), its investigational 25-valent pneumococcal conjugate vaccine candidate, in…
-
Prilenia and Ferrer secure EU authorisation for Phase III HD trial
Prilenia Therapeutics and Ferrer have secured EU authorisation to begin PRECISE-HD, a confirmatory Phase III trial of pridopidine to treat Huntington’s…
-
Granata Bio concludes screening in Phase III GRACE trial for IVF
Granata Bio has completed participant screening in its Phase III GRACE trial of Granata Bio human menopausal gonadotropin (GB-hMG) in…